154 related articles for article (PubMed ID: 10831268)
1. Effects of prostacyclin inhibition on splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension.
Wang SS; Chu CJ; Lee FY; Wu SL; Lin HC; Chan CC; Chang FY; Lee SD
Scand J Gastroenterol; 2000 Apr; 35(4):426-32. PubMed ID: 10831268
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of prostacyclin by indomethacin ameliorates the splanchnic hyposensitivity to glypressin in haemorrhage-transfused common bile duct-ligated rats.
Lee FY; Chu CJ; Wang SS; Chang FY; Lin HC; Hou MC; Chan CC; Wu SL; Chen CT; Huang HC; Lee SD
Eur J Clin Invest; 2001 Feb; 31(2):145-53. PubMed ID: 11168453
[TBL] [Abstract][Full Text] [Related]
3. Chronic inhibition of nitric oxide ameliorates splanchnic hyposensitivity to glypressin in a hemorrhage-transfused rat model of portal hypertension.
Huang HC; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Chan CC; Wu SL; Chen CT; Lee SD
Scand J Gastroenterol; 2000 Dec; 35(12):1308-13. PubMed ID: 11199372
[TBL] [Abstract][Full Text] [Related]
4. Aminoguanidine ameliorates splanchnic hyposensitivity to glypressin in a haemorrhage-transfused rat model of portal hypertension.
Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Hou MC; Wu SL; Tai CC; Chan CC; Lee SD
Clin Sci (Lond); 1998 Nov; 95(5):629-36. PubMed ID: 9791050
[TBL] [Abstract][Full Text] [Related]
5. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin.
Chen CT; Chu CJ; Lee FY; Chang FY; Wang SS; Lin HC; Hou MC; Wu SL; Chan CC; Huang HC; Lee SD
Hepatogastroenterology; 2009; 56(94-95):1261-7. PubMed ID: 19950773
[TBL] [Abstract][Full Text] [Related]
6. Splanchnic hyposensitivity to glypressin in a haemorrhage/transfused rat model of portal hypertension: role of nitric oxide and bradykinin.
Chu CJ; Wu SL; Lee FY; Wang SS; Chang FY; Lin HC; Chan CC; Lee SD
Clin Sci (Lond); 2000 Dec; 99(6):475-82. PubMed ID: 11099389
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase expression in splanchnic hyposensitivity to glypressin of bleeding portal hypertensive rats.
Huang HC; Wang SS; Chen YC; Lee FY; Chang FY; Lin HC; Hou MC; Chan CC; Chen CT; Wu SL; Lee SD
Eur J Clin Invest; 2003 Jun; 33(6):505-12. PubMed ID: 12795648
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase expression in the splanchnic hyposensitivity to glypressin of a hemorrhage-transfused rat model with portal hypertension.
Huang HC; Chen YC; Wang SS; Chan CC; Lee FY; Chang FY; Lin HC; Hou MC; Lu RH; Wu SL; Lee SD
J Chin Med Assoc; 2004 Jun; 67(6):268-74. PubMed ID: 15366403
[TBL] [Abstract][Full Text] [Related]
9. Adrenal dysfunction in portal hypertensive rats with acute hemorrhage.
Lee FY; Wang SS; Tsai MH; Huang HC; Lin HC; Lee SD
PLoS One; 2014; 9(3):e92093. PubMed ID: 24633079
[TBL] [Abstract][Full Text] [Related]
10. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension.
Xu J; Cao H; Liu H; Wu ZY
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497
[TBL] [Abstract][Full Text] [Related]
11. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.
Bernadich C; Bandi JC; Melin P; Bosch J
Hepatology; 1998 Feb; 27(2):351-6. PubMed ID: 9462630
[TBL] [Abstract][Full Text] [Related]
12. Haemodynamic responses to a combination of terlipressin and octreotide in portal hypertensive rats.
Moreau R; Cailmail S; Valla D; Lebrec D
Aliment Pharmacol Ther; 1997 Oct; 11(5):993-7. PubMed ID: 9354212
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of glucagon improves splanchnic hyporesponse to terlipressin in cirrhotic rats with blood retention in the gastric lumen.
Yang YY; Lin HC; Huang YT; Hou MC; Lee FY; Chang FY; Lee SD
J Hepatol; 2005 May; 42(5):652-8. PubMed ID: 15826713
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension.
Hartl J; Dietrich P; Moleda L; Müller-Schilling M; Wiest R
Liver Int; 2015 Dec; 35(12):2556-63. PubMed ID: 26010514
[TBL] [Abstract][Full Text] [Related]
15. Effect of terlipressin on in vitro vascular hyporeactivity of portal hypertensive rats.
Heinemann A; Stauber RE
J Hepatol; 1996 Jun; 24(6):739-46. PubMed ID: 8835750
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of terlipressin and octreotide administration alone or in combination in portal hypertensive rats.
Oberti F; Veal N; Kaassis M; Pilette C; Rifflet H; Trouvé R; Calès P
J Hepatol; 1998 Jul; 29(1):103-11. PubMed ID: 9696498
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of acute tetrandrine and terlipressin administration on portal hypertensive rats.
Huang YT; Tsai JF; Lin HC; Chen CF; Hong CY
Can J Physiol Pharmacol; 1997; 75(10-11):1220-5. PubMed ID: 9431446
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of combined terlipressin and tetramethylpyrazine administration on portal hypertensive rats.
Chang FC; Huang YT; Lin HC; Hong CY; Lin JG; Chen KJ
Can J Physiol Pharmacol; 1999 Aug; 77(8):618-24. PubMed ID: 10543725
[TBL] [Abstract][Full Text] [Related]
19. Time profile of the haemodynamic effects of terlipressin in portal hypertension.
Escorsell A; Bandi JC; Moitinho E; Feu F; García-Pagan JC; Bosch J; Rodés J
J Hepatol; 1997 Mar; 26(3):621-7. PubMed ID: 9075670
[TBL] [Abstract][Full Text] [Related]
20. Role of PGI2 in the formation and maintenance of hyperdynamic circulatory state of portal hypertensive rats.
Wu ZY; Chen XS; Qiu JF; Cao H
World J Gastroenterol; 2005 Feb; 11(5):752-5. PubMed ID: 15655838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]